Beijing Beilu Pharmaceutical Co Ltd
SZSE:300016
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Beijing Beilu Pharmaceutical Co Ltd
SZSE:300016
|
CN |
|
G
|
Gotion High tech Co Ltd
SZSE:002074
|
CN |
|
Shandong Longquan Pipeline Engineering Co Ltd
SZSE:002671
|
CN |
|
Chemometec A/S
F:CHY
|
DK |
|
A
|
Adecoagro SA
F:ACD
|
LU |
|
L
|
Lexington Biosciences Holdings Corp
OTC:LXGTF
|
CA |
|
D
|
Destiny Tech100 Inc
NYSE:DXYZ
|
US |
|
Seres Therapeutics Inc
NASDAQ:MCRB
|
US |
|
Alpek SAB de CV
BMV:ALPEKA
|
MX |
|
Guangzhou Tech-Long Packaging Machinery Co Ltd
SZSE:002209
|
CN |
|
EnPro Industries Inc
NYSE:NPO
|
US |
|
DLH Holdings Corp
NASDAQ:DLHC
|
US |
|
H
|
Hyundai Corp
KRX:011760
|
KR |
|
S
|
Shannon Semiconductor Technology Co Ltd
SZSE:300475
|
CN |
|
QuakeSafe Technologies Co Ltd
SZSE:300767
|
CN |
|
B
|
Baker Hughes Co
LSE:0RR8
|
US |
Bankruptcy Probability
Beijing Beilu Pharmaceutical Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Beijing Beilu Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
B
|
Beijing Beilu Pharmaceutical Co Ltd
SZSE:300016
|
5.6B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Beijing Beilu Pharmaceutical Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Beijing Beilu Pharmaceutical Co Ltd has total debt of 821.5m CNY. This includes both short-term (161.6m CNY) and long-term (659.9m CNY) debt.
You can find a full breakdown on its Balance Sheet.
